文献速递创伤与烧伤呼吸衰竭与机械通气

出院前移除可回收下腔静脉滤器是否与肺栓塞发生率增加相关

Removal of retrievable inferior vena cava filters before discharge: Is it associated with increased incidence of pulmonary embolism?
PubMed 文献 · J Trauma Acute Care Surg · 2019-01-01
一句话结论严重创伤患者可抗凝后出院前移除可回收下腔静脉滤器,取出后6个月内肺栓塞发生率0%,作者认为安全且可提高取出率。

该研究回顾2006年1月至2018年8月放置并移除可回收下腔静脉滤器的创伤患者,比较出院前移除与出院后移除两组在滤器移除后6个月内肺栓塞发生率。共放置281枚滤器,218枚符合移除条件,72.4%(158/218)被取出,其中63%(100/158)在出院前移除。出院前组与出院后组平均滤器留置时间分别为26天和103天,除滤器指征外两组人口学与临床因素分布无差异(静脉血栓栓塞指征出院后组95% vs 出院前组74%,p=0.0043)。移除后肺栓塞发生率出院前组0%、出院后组1%(Fisher精确检验p=1.000)。作者认为,患者可适当抗凝后出院前移除滤器是提高取出率的安全策略。

要点

  • 创伤患者放置可回收下腔静脉滤器后,出院前移除组移除后6个月内肺栓塞发生率为0%,出院后移除组为1%(p=1.000)。
  • 共218枚滤器符合移除条件,72.4%(158/218)被取出,其中63%(100/158)在出院前移除。
  • 出院前移除组平均滤器留置时间26天,出院后移除组103天。
  • 除滤器指征外,两组人口学与临床因素分布无差异(静脉血栓栓塞指征出院后组95% vs 出院前组74%,p=0.0043)。
  • 作者认为,患者可适当抗凝后出院前移除滤器是提高取出率的安全策略。

适用人群与场景

  • 2006年1月至2018年8月期间放置并移除可回收下腔静脉滤器的创伤患者。
  • 严重创伤患者存在深静脉血栓和肺栓塞高风险,且可能有预防性或治疗性抗凝禁忌。

诊断标准与关键阈值

  • 暴露因素为滤器移除时机:出院前移除或出院后移除。
  • 结局指标为滤器移除后6个月内是否有记录的肺栓塞。

研究设计与关键结果

  • 研究类型为回顾性记录审查,纳入2006年1月至2018年8月放置并移除可回收下腔静脉滤器的创伤患者,收集从入院至滤器移除后6个月的数据。
  • 共放置281枚可回收下腔静脉滤器,218枚符合移除条件,72.4%(158/218)被取出,其中63%(100/158)在出院前移除。
  • 出院前移除组平均滤器留置时间26天,出院后移除组103天。
  • 除滤器指征外,两组人口学与临床因素分布无差异(p>0.05);静脉血栓栓塞指征出院后组95% vs 出院前组74%,p=0.0043。
  • 移除后肺栓塞发生率出院前组0%、出院后组1%,Fisher精确检验p=1.000。

证据类型、等级与局限

  • 证据类型为回顾性研究,证据等级为治疗性,level V。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,患者可适当抗凝后出院前移除可回收下腔静脉滤器是提高取出率的安全策略,移除后6个月内肺栓塞发生率出院前组0%、出院后组1%(p=1.000)。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: Severely injured trauma patients are at high risk of developing deep venous thrombosis and pulmonary emboli (PE), and may have contraindications to prophylactic or therapeutic anticoagulation. Retrievable inferior vena cava filters (rIVCFs) are used to act as a mechanical obstruction to prevent PE in high risk populations and those with deep venous thrombosis who cannot be anticoagulated. The removal rate of rIVCFs is variable in trauma centers, including our previous published rate of 50% to 89%/year. Indwelling filters carry a risk of significant morbidity and the success of retrieval decreases as the dwell time increases. We hypothesized that once patients could receive appropriate prophylactic or therapeutic anticoagulation, rIVCF could be removed before hospital discharge without impact on occurrence or recurrence of PE.

METHODS: All trauma patients with rIVCF placed and removed between January 2006 and August 2018 were reviewed. We collected data from record review from admission to 6 months postfilter removal, including demographics, filter indication, filter type, dwell time, placement and removal complications, antithrombosis medications, location of venous thromboembolism, complications, and discharge disposition. Exposure of interest was timing of filter removal: before (BEF) or after hospital discharge (AFT). The outcome of interest was whether the patient had a documented PE within 6 months of filter removal.

RESULTS: A total of 281 rIVCFs were placed, 218 were eligible for removal, 72.4% (158/218) were retrieved with 63% (100/158) removed before discharge. Mean filter duration was 26 days and 103 days for the before and after groups, respectively. No differences (p > 0.05) were noted in the distribution of demographic and clinical factors except for filter indication (venous thromboembolism indication, 95% in AFT vs. 74% in BEF, p = 0.0043). Postremoval PE rates were 0% BEF and 1% AFT (Fisher's exact test, p = 1.000).

CONCLUSION: Our results suggest that removal of rIVCFs before discharge once patients are appropriately anticoagulated is a safe strategy to improve retrieval rates.

LEVEL OF EVIDENCE: Therapeutic, level V.

来源:J Trauma Acute Care Surg,查看原文。版权归原作者所有。

参考来源

  1. Robbins JM, Garwe T, McCarthy CK, et al. Removal of retrievable inferior vena cava filters before discharge: Is it associated with increased incidence of pulmonary embolism? J Trauma Acute Care Surg. 2019. PMID: 31166290. doi:10.1097/TA.0000000000002395

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。